IL-25, which is increased in IPF lungs, induces IL-13-expressing ILC2 expansion, while IL-33 further enhances ILC2 activation and M2 macrophage polarization, leading to increased IL-13 and TGF-β production (158–160). Here, TGFB1 is linked to idiopathic pulmonary fibrosis.